School of Medicine scientist explores new approach to treating blood clot-induced lung tissue damage
April 02, 2026, Chris Horn
Blood clots in the lungs are a leading cause of cardiovascular-related deaths. But what if gene editing, made possible through ultra-small nanoparticles, could effectively treat clot-induced tissue damage? For USC School of Medicine Columbia scientist Colin Evans, the question is no longer hypothetical.